— by Colin Todhunter — 03/06/2021
On 25 May 2021, the Indian Bar Association (IBA) served a 51-page legal notice on Dr Soumya Swaminathan, the Chief Scientist at the World Health Organisation (WHO), for “her act of spreading disinformation and misguiding the people of India, in order to fulfil her agenda.”
The Mumbai-based IBA is an association of lawyers who strive to bring transparency and accountability to the Indian justice system. It is actively involved in the dissemination of legal knowledge and provides guidance and support to advocates and ordinary people in their fight for justice.
The legal notice says Dr Swaminathan has been:
“Running a disinformation campaign against Ivermectin by deliberate suppression of effectiveness of drug Ivermectin as prophylaxis and for treatment of COVID-19, despite the existence of large amounts of clinical data compiled and presented by esteemed, highly qualified, experienced medical doctors and scientists,”
“Issuing statements in social media and mainstream media, thereby influencing the public against the use of Ivermectin and attacking the credibility of acclaimed bodies/institutes like ICMR and AIIMS, Delhi, which have included ‘Ivermectin’ in the ‘National Guidelines for COVID-19 management’.”
The IBA states that legal action is being taken against Dr Swaminathan in order to stop her from causing further damage to the lives of citizens of India.
The notice is based on the research and clinical trials carried out by the ‘Front Line COVID-19 Critical Care Alliance’ (FLCCC) and the British Ivermectin Recommendation Development (BIRD) Panel. These organisations have presented an enormous amount of data that strengthen the case for recommending Ivermectin for the prevention and treatment of COVID-19.
The IBA says that Dr Swaminathan has ignored these studies and reports and has deliberately suppressed the data regarding the effectiveness of Ivermectin, with an intent to dissuade the people of India from using it.
However, two key medical bodies, the Indian Council for Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) Delhi, have refused to accept her stand and have retained the recommendation for Ivermectin, under a ‘May Do’ category, for patients with mild symptoms and those in home isolation, as stated in ‘The National Guidelines for COVID-19 management’.
It is interesting to note that the content of several web links to news articles and reports included in the notice served upon Dr Swaminathan, which was visible before issuing the notice, has either been removed or deleted.
It seems that the vaccine manufacturers and many governments are desperate to protect their pro-vaccine agenda and will attempt to censor information and news regarding the efficacy of Ivermectin.
The legal notice can be read in full on the website of the India Bar Association.
Colin Todhunter is an independent writer specialising in Development, food and agriculture